These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
325 related articles for article (PubMed ID: 9618995)
1. [Immediate-acting oral morphine sulfate in patients with cancer pain]. Montejo-Rosas G; Flores-Siordia R; Castañeda-de la Lanz C; Zavala-Sánchez A; Nápoles-Echauri A Gac Med Mex; 1998; 134(2):161-7. PubMed ID: 9618995 [TBL] [Abstract][Full Text] [Related]
2. Oral versus intravenous opioid dosing for the initial treatment of acute musculoskeletal pain in the emergency department. Miner JR; Moore J; Gray RO; Skinner L; Biros MH Acad Emerg Med; 2008 Dec; 15(12):1234-40. PubMed ID: 18945240 [TBL] [Abstract][Full Text] [Related]
3. Pain management of opioid-treated cancer patients in hospital settings in Denmark. Lundorff L; Peuckmann V; Sjøgren P Acta Anaesthesiol Scand; 2008 Jan; 52(1):137-42. PubMed ID: 18005379 [TBL] [Abstract][Full Text] [Related]
4. Long-acting morphine for pain control in paediatric oncology. Zernikow B; Lindena G Med Pediatr Oncol; 2001 Apr; 36(4):451-8. PubMed ID: 11260568 [TBL] [Abstract][Full Text] [Related]
5. [Effects of sustained release morphine hydrochloride tablets in management of cancer pain: a survey of 567 patients]. Yu SY; Qiu H; Ma ZS; Chen J; Zhang Y; Chen LZ; Wang DL; Ma ZY Zhonghua Yi Xue Za Zhi; 2004 Mar; 84(6):450-5. PubMed ID: 15061959 [TBL] [Abstract][Full Text] [Related]
6. The intravenous to oral relative milligram potency ratio of morphine during chronic dosing in cancer pain. Lasheen W; Walsh D; Mahmoud F; Sarhill N; Rivera N; Davis M; Lagman R; Legrand S Palliat Med; 2010 Jan; 24(1):9-16. PubMed ID: 19910396 [TBL] [Abstract][Full Text] [Related]
7. Safety and effectiveness of intravenous morphine for episodic (breakthrough) pain using a fixed ratio with the oral daily morphine dose. Mercadante S; Villari P; Ferrera P; Bianchi M; Casuccio A J Pain Symptom Manage; 2004 Apr; 27(4):352-9. PubMed ID: 15050663 [TBL] [Abstract][Full Text] [Related]
8. [Morphine dose and side effects: a comparison of older and younger patients with tumor pain]. Loick G; Radbruch L; Sabatowski R; Siessegger M; Grond S; Lehmann KA Dtsch Med Wochenschr; 2000 Oct; 125(41):1216-21. PubMed ID: 11076259 [TBL] [Abstract][Full Text] [Related]
9. Rapid titration with intravenous morphine for severe cancer pain and immediate oral conversion. Mercadante S; Villari P; Ferrera P; Casuccio A; Fulfaro F Cancer; 2002 Jul; 95(1):203-8. PubMed ID: 12115334 [TBL] [Abstract][Full Text] [Related]
10. Dose ratio between morphine and methadone in patients with cancer pain: a retrospective study. Lawlor PG; Turner KS; Hanson J; Bruera ED Cancer; 1998 Mar; 82(6):1167-73. PubMed ID: 9506365 [TBL] [Abstract][Full Text] [Related]
11. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone). Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626 [TBL] [Abstract][Full Text] [Related]
12. A prospective study evaluating the response of patients with unrelieved cancer pain to parenteral opioids. Enting RH; Oldenmenger WH; van der Rijt CC; Wilms EB; Elfrink EJ; Elswijk I; Sillevis Smitt PA Cancer; 2002 Jun; 94(11):3049-56. PubMed ID: 12115396 [TBL] [Abstract][Full Text] [Related]
13. Continuous intrathecal morphine infusion in patients with vertebral fractures due to osteoporosis. Shaladi A; Saltari MR; Piva B; Crestani F; Tartari S; Pinato P; Micheletto G; Dall'Ara R Clin J Pain; 2007; 23(6):511-7. PubMed ID: 17575491 [TBL] [Abstract][Full Text] [Related]
14. Safety and effectiveness of intravenous morphine for episodic breakthrough pain in patients receiving transdermal buprenorphine. Mercadante S; Villari P; Ferrera P; Porzio G; Aielli F; Verna L; Casuccio A J Pain Symptom Manage; 2006 Aug; 32(2):175-9. PubMed ID: 16877185 [TBL] [Abstract][Full Text] [Related]
15. A randomized, double-blind, multi-site, crossover, placebo-controlled equivalence study of morning versus evening once-daily sustained-release morphine sulfate in people with pain from advanced cancer. Currow DC; Plummer JL; Cooney NJ; Gorman D; Glare PA J Pain Symptom Manage; 2007 Jul; 34(1):17-23. PubMed ID: 17601560 [TBL] [Abstract][Full Text] [Related]
16. A randomized clinical trial of oral transmucosal fentanyl citrate versus intravenous morphine sulfate for initial control of pain in children with extremity injuries. Mahar PJ; Rana JA; Kennedy CS; Christopher NC Pediatr Emerg Care; 2007 Aug; 23(8):544-8. PubMed ID: 17726413 [TBL] [Abstract][Full Text] [Related]
17. Clinical aspects and treatment of pain in children and adolescents with cancer. Monteiro Caran EM; Dias CG; Seber A; Petrilli AS Pediatr Blood Cancer; 2005 Dec; 45(7):925-32. PubMed ID: 16106427 [TBL] [Abstract][Full Text] [Related]
18. [Nociceptive cancer pain in adult patients: statement about guidelines related to the use of antinociceptive medicine]. Binhas M; Krakowski I; Marty J Ann Fr Anesth Reanim; 2007 Jun; 26(6):502-15. PubMed ID: 17560755 [TBL] [Abstract][Full Text] [Related]
20. Comparison of TTS-fentanyl with sustained-release oral morphine in the treatment of patients not using opioids for mild-to-moderate pain. van Seventer R; Smit JM; Schipper RM; Wicks MA; Zuurmond WW Curr Med Res Opin; 2003; 19(6):457-69. PubMed ID: 14594516 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]